INTRODUCTION
Traditional tumor therapies have limited efficacy, leading to a high mortality rate. Although immunotherapy holds considerable therapeutic promise, clinical immunotherapy for solid tumors only elicits durable responses in a minority of patients. This limitation is largely attributed to the highly immunosup...
Hui-Xi Yi, Chao Jiang, Zheng-Yin Pan et al.· Journal of Advanced Research· 0 citations
In vitro and in vivo investigations demonstrate that PR nanohybrid exhibits superior anticancer efficacy over free Oxa and displays promising potential in combination with PD‐1 blockade therapy, offering a novel strategy to advance platinum‐based combination cancer therapy.
Huixi Yi, Yue Zheng, Nan-Nan Fu et al.· Advanced Healthcare Material...· 0 citations
Controllable structural transformation of DNA nanostructures offers substantial potential for molecular devices. Toehold-mediated strand displacement, a common strategy for driving such rearrangements, generally requires a dedicated toehold sequence to initiate the reaction, making the regulation of conformational chan...